HealthCare Global Enterprises Limited Share Price and Company Fundamentals
Last traded: Today at 10:00 AM
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, psycho-oncology, targeted drug therapy, bone marrow transplant, pediatric oncology, organ preservation and reconstructive surgery, endocrine therapy, and liver transplant; and post care services, including patient care, psychological support, nutrition, multidisciplinary rehabilitation, and genetic counselling. It also provides cancer screening, interventional radiology, MRI, nephrology, clinical trial, hormone therapy, hematology, CAR T cell, yoga therapy, bone marrow transplant, organ-specific oncology, radiation oncology, liver transplantation, radiology and imaging, clinical laboratory, day care chemotherapy center, home health care, preventive and psycho oncology, translational and nuclear medicine, oncodermatology, paediatric and gynaecologic oncology, anaesthesiology, and orthopaedic oncology. In addition, the company offers gastrointestinal and thoracic oncology, breast surgical oncology, and pain and palliative services. Further, it operates multi-specialty hospitals under the HCG brand that offers inpatient and outpatient treatments with specialties in cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine and pulmonary, and critical care; and provides oncology diagnostics services, including biomarkers, translational research, and clinical research services under the Triesta Sciences brand. HealthCare Global Enterprises Limited was founded in 1989 and is headquartered in Bengaluru, India.
Key Metrics
PE ratio
441.97
PB ratio
7.54
Dividend yield
-
Beta
-0.03
Market cap
₹103.60B
Enterprise value
₹117.63B
Company profile
| Industry / Sector | Medical Care Facilities / Healthcare |
|---|---|
| Full time employees | 6761 |
| Website | https://www.hcgoncology.com |
| Mailing address | Unity Building Complex Ground Foor No. 3, Tower Block Mission Road Bengaluru 560027 India |
| Phone / Fax | 91 80 4660 7700 / |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
HealthCare Global Enterprises Limited paid ₹- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.HCG dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Sep 2026, following are the company executives and directors listed on HealthCare Global Enterprises Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Ms. Sunu Manuel Abey | Compliance Officer & Company Secretary | ||
| Dr. Manish Mattoo | CEO & Executive Director | ||
| Mr. Sanjeev Kumar Saxena B.Com (Hons), CA, CS | Chief Financial Officer | 60 | |
| V. Venkataramanan | Senior Vice President of Finance & Accounts | 51 | |
| Mr. Pankaj Gautam | Chief Technology & Security Officer and Chief Information Officer | ||
| Mr. Ravi Gothwal | Assistant VP of Investor Relations | ||
| Mr. Madan Kumar Sampath | Chief Supply Chain Officer | ||
| Dr. Rupali Basu | Senior Vice President of Regional Business Head (East & AP) | 62 |
Profitability and management effectiveness
Profit margin
0.87%
Operating margin
7.46%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of HealthCare Global Enterprises Limited is 103.60B and its enterprise value is 117.63B. The enterprise value to revenue ratio of HCG is 4.48. The enterprise value to EBITDA ratio of HCG is 23.76.
HealthCare Global Enterprises Limited (NSE:HCG) Frequently Asked Questions
1. What is HealthCare Global Enterprises Limited's Stock Symbol?
HealthCare Global Enterprises Limited trades on NSE under the ticker symbol "HCG".
2. What is HealthCare Global Enterprises Limited's stock price today?
One share of HCG stock can currently be purchased for approximately ₹693.9.
3. How can I contact HealthCare Global Enterprises Limited?
HealthCare Global Enterprises Limited's mailing address is Unity Building Complex Ground Foor No. 3, Tower Block Mission Road Bengaluru 560027 India. The company can be reached via phone at 91 80 4660 7700.
4. What is HealthCare Global Enterprises Limited's official website?
The official website of HealthCare Global Enterprises Limited is https://www.hcgoncology.com.